These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8894407)

  • 1. Monoclonal gammopathy and neuropathy.
    Notermans NC
    Curr Opin Neurol; 1996 Oct; 9(5):334-7. PubMed ID: 8894407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polyneuropathies and monoclonal gammopathies, so-called benign].
    Vallat JM; Jauberteau MO; Arbo-Oze-de-Morvil C; Tabaraud F
    Rev Prat; 1992 Jan; 42(1):43-5. PubMed ID: 1314413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cells.
    Hellqvist E; Kvarnström M; Söderberg A; Vrethem M; Ernerudh J; Rosén A
    Haematologica; 2010 Apr; 95(4):627-36. PubMed ID: 20015874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.
    Latov N
    Ann Neurol; 1995 May; 37 Suppl 1():S32-42. PubMed ID: 8968215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurological manifestations of monoclonal gammopathies].
    Chassande B; Léger JM
    Rev Prat; 1993 Feb; 43(3):314-6. PubMed ID: 8389055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins.
    Ilyas AA; Quarles RH; Dalakas MC; Brady RO
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6697-700. PubMed ID: 2413445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Siciliano G; Moriconi L; Gianni G; Richieri E; Vignocchi MG; Rossi B
    Acta Neurol Scand; 1994 Feb; 89(2):117-22. PubMed ID: 8191874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases.
    Chassande B; Léger JM; Younes-Chennoufi AB; Bengoufa D; Maisonobe T; Bouche P; Baumann N
    Muscle Nerve; 1998 Jan; 21(1):55-62. PubMed ID: 9427224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy and neuropathy.
    Latov N
    Ann Neurol; 1992 Jun; 31(6):690-1. PubMed ID: 1381170
    [No Abstract]   [Full Text] [Related]  

  • 10. IgM MGUS anti myelin-associated glycoprotein neuropathy can rarely express as a predominantly distal motor neuropathy.
    Galassi G; Tondelli M
    Muscle Nerve; 2016 May; 53(5):827-8. PubMed ID: 26690862
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal gammopathy and neuropathy.
    Pestronk A
    Ann Neurol; 1992 Jun; 31(6):689; author reply 690-1. PubMed ID: 1381169
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside.
    Daune GC; Farrer RG; Dalakas MC; Quarles RH
    Ann Neurol; 1992 Jun; 31(6):683-5. PubMed ID: 1381168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S; Kyle RA; Dyck PJ
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy.
    Ponsford S; Willison H; Veitch J; Morris R; Thomas PK
    Muscle Nerve; 2000 Feb; 23(2):164-74. PubMed ID: 10639606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peripheral neuropathies associated with monoclonal gammapathies. Value of electrophysiologic studies].
    Bouche P; Bouchacourt E; Leger JM; Travers MA; Cathala HP
    Rev Electroencephalogr Neurophysiol Clin; 1985 Dec; 15(3):255-65. PubMed ID: 3006187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of neutralizing autoantibodies to interferon-gamma in patients with polyneuropathy.
    Elkarim RA; Mustafa M; Link H; Bakhiet M; Ekerfelt C; Vrethem M; Ernerudh J
    Hum Antibodies; 1999; 9(1):55-60. PubMed ID: 10331186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correspondence: The association between morphea profunda and monoclonal gammopathy: A case series.
    Endo J; Strickland N; Grewal S; Vandergriff T; Keenan T; Longley BJ; Jacobe H
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
    Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
    Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathies of monoclonal gammopathies of undetermined significance.
    Kelly JJ
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1203-10. PubMed ID: 10626145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy.
    Simovic D; Gorson KC; Ropper AH
    Acta Neurol Scand; 1998 Mar; 97(3):194-200. PubMed ID: 9531437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.